Aura Biosciences Inc (AURA) — Financial Flexibility Index
Aura Biosciences Inc (AURA) has a Financial Flexibility Index of -0.60x as of September 2025. Free cash flow of $-20.10 Million (operating CF $-20.14 Million minus capex $45.00K) represents -1% of total liabilities ($33.36 Million). Also explore Aura Biosciences Inc annual equity growth to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Aura Biosciences Inc Financial Flexibility Index (2019–2024)
Historical Financial Flexibility Index trend for Aura Biosciences Inc across 6 annual periods. Check Aura Biosciences Inc (AURA) strategic asset index to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Aura Biosciences Inc (2019–2024)
Year-by-year free cash flow to debt coverage for Aura Biosciences Inc. For the full company profile including market capitalisation, see AURA stock market capitalisation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -2.57x | $-78.55 Million | $-79.81 Million | $30.53 Million | ▼ -19.1% |
| 2023 | -2.16x | $-63.14 Million | $-63.85 Million | $29.23 Million | ▼ -14.5% |
| 2022 | -1.89x | $-53.51 Million | $-54.60 Million | $28.35 Million | ▲ +51.9% |
| 2021 | -3.93x | $-30.29 Million | $-32.41 Million | $7.71 Million | ▲ +54.3% |
| 2020 | -8.59x | $-23.55 Million | $-24.32 Million | $2.74 Million | ▼ -193.1% |
| 2019 | -2.93x | $-18.45 Million | $-20.67 Million | $6.29 Million | — |